Home > Healthcare > Medical Devices > Therapeutic Devices > Extracorporeal Membrane Oxygenation Market
Extracorporeal Membrane Oxygenation Market Share
- Report ID: GMI2720
- Published Date: Apr 2023
- Report Format: PDF
Extracorporeal Membrane Oxygenation Market Share
The global extracorporeal membrane oxygenation market consists of several players including:
- Abbott Laboratories
- Fresenius Medical Care AG & Co
- KGaA
- Braile Biomedica
- Edwards Lifesciences Corporation
- Abiomed
- Eurosets
- Getinge AB
- LivaNova PLC
- Medtronic
- MicroPort Scientific Corporation
- Nipro
- SB-Kawasumi Laboratories Inc
- Spectrum Medical,
- Terumo Corporation
Frequently Asked Questions (FAQ) :
Global market for ECMO stood at over USD 490 million in 2022 and is expanding consistently at more than 3% CAGR driven by the increasing prevalence of respiratory failure and cardiopulmonary diseases.
Extracorporeal cardiopulmonary resuscitation (ECPR) segment is expected to accumulate over 5% market share by 2032 owing to the increasing incidences of sudden cardiac arrests.
Ppediatric segment garnered over USD 100 million in 2022 driven by the increasing prevalence of several pediatric diseases, such as pneumonia, meconium aspiration syndrome, respiratory distress syndrome (RDS), and congenital diaphragmatic hernia (CDH).
North America amassed over 58% share of ECMO market in 2022 due to the increasing elderly populace and the considerable growth in healthcare expenditure across the region.
Extracorporeal Membrane Oxygenation Market Scope
×
Get a free sample of
Extracorporeal Membrane Oxygenation Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below